Earnings for most of the nation's major pharmaceutical makers are believed to have moved ahead briskly in the third quarter,@#%^&*('believed', 'ROOT', 'R')	
as companies with newer, big-selling prescription drugs fared especially well.@#%^&*('companies', 'moved', 'U')	
For the third consecutive quarter, however, most of the companies' revenues were battered by adverse foreign-currency translations@#%^&*('battered', 'ROOT', 'R')	('a', 'result', 'U')	
as a result of the strong dollar abroad.@#%^&*('result', 'translations', 'U')	('abroad', 'battered', 'U')	
Analysts said@#%^&*('said', 'ROOT', 'R')	
that Merck & Co., Eli Lilly & Co., Warner-Lambert Co. and the Squibb Corp. unit of Bristol-Myers Squibb Co. all benefited from strong sales of relatively new, higher-priced medicines@#%^&*('benefited', 'said', 'U')	('medicines', 'provide', 'U')	
that provide wide profit margins.@#%^&*('provide', 'medicines', 'U')	
Less robust earnings at Pfizer Inc. and Upjohn Co. were attributed to those companies' older products,@#%^&*('attributed', 'ROOT', 'R')	
many of which face stiffening competition from generic drugs and other medicines.@#%^&*('stiffening', 'products', 'U')	
Joseph Riccardo, an analyst with Bear, Stearns & Co., said@#%^&*('said', 'ROOT', 'R')	
that over the past few years most drug makers have shed their slow-growing businesses@#%^&*('makers', 'instituted', 'U')	('shed', 'said', 'U')	
and instituted other cost savings,@#%^&*('instituted', 'said', 'U')	('instituted', 'shed', 'U')	
such as consolidating manufacturing plants and administrative staffs.@#%^&*('consolidating', 'savings', 'U')	
As a result, "major new products are having significant impact, even on a company with very large revenues,"@#%^&*('result', 'said', 'U')	('having', 'said', 'U')	
Mr. Riccardo said.@#%^&*('said', 'ROOT', 'R')	
Analysts said@#%^&*('said', 'ROOT', 'R')	
profit for the dozen or so big drug makers, as a group, is estimated to have climbed between 11% and 14%.@#%^&*('estimated', 'said', 'U')	
While that's not spectacular,@#%^&*('spectacular', 'said', 'U')	
Neil Sweig, an analyst with Prudential Bache, said@#%^&*('said', 'ROOT', 'R')	
that the rate of growth will "look especially good@#%^&*('look', 'said', 'U')	
as compared to other companies@#%^&*('compared', 'good', 'U')	
if the economy turns downward."@#%^&*('turns', 'look', 'U')	
Mr. Sweig estimated@#%^&*('estimated', 'ROOT', 'R')	
that Merck's profit for the quarter rose by about 22%,@#%^&*('rose', 'estimated', 'U')	
propelled by sales of its line-up of fast-growing prescription drugs,@#%^&*('propelled', '%', 'U')	
including its anti-cholesterol drug, Mevacor; a high blood pressure medicine, Vasotec; Primaxin, an antibiotic, and Pepcid, an anti-ulcer medication.@#%^&*('drug', 'rose', 'U')	('Pepcid', 'rose', 'U')	
Profit climbed@#%^&*('climbed', 'ROOT', 'R')	
even though Merck's sales were reduced by "one to three percentage points"@#%^&*('reduced', 'said', 'U')	('a', 'result', 'U')	
as a result of the strong dollar,@#%^&*('result', 'reduced', 'U')	
Mr. Sweig said.@#%^&*('said', 'climbed', 'U')	
In the third quarter of 1988, Merck earned $311.8 million, or 79 cents a share.@#%^&*('earned', 'ROOT', 'R')	
In Rahway, N.J., a Merck spokesman said@#%^&*('said', 'ROOT', 'R')	
the company doesn't make earnings projections.@#%^&*('make', 'said', 'U')	
Mr. Sweig said@#%^&*('said', 'ROOT', 'R')	
he estimated@#%^&*('estimated', 'said', 'U')	
that Lilly's earnings for the quarter jumped about 20%,@#%^&*('jumped', 'estimated', 'U')	
largely because of the performance of its new anti-depressant Prozac.@#%^&*('largely', '%', 'U')	('performance', '%', 'U')	
The drug,@#%^&*('drug', 'expected', 'U')	('drug', 'generate', 'U')	
introduced last year,@#%^&*('introduced', 'drug', 'U')	
is expected to generate sales of about $300 million this year.@#%^&*('expected', 'ROOT', 'R')	
"It's turning out to be a real blockbuster,"@#%^&*('turning', 'said', 'U')	
Mr. Sweig said.@#%^&*('said', 'ROOT', 'R')	
In last year's third quarter, Lilly earned $171.4 million, or $1.20 a share.@#%^&*('earned', 'ROOT', 'R')	
In Indianapolis, Lilly declined comment.@#%^&*('declined', 'ROOT', 'R')	
Several analysts said@#%^&*('said', 'reported', 'U')	
they expected Warner-Lambert's profit also to increase by more than 20% from $87.7 million, or $1.25 a share,@#%^&*('expected', 'said', 'U')	('it', 'reported', 'U')	
it reported in the like period last year.@#%^&*('reported', 'ROOT', 'R')	
The company is praised by analysts@#%^&*('praised', 'ROOT', 'R')	
for sharply lowering its costs in recent years@#%^&*('lowering', 'analysts', 'U')	
and shedding numerous companies with low profit margins.@#%^&*('shedding', 'analysts', 'U')	('shedding', 'lowering', 'U')	
The company's lean operation,@#%^&*('operation', 'allowed', 'U')	
analysts said,@#%^&*('said', 'allowed', 'U')	
allowed sharp-rising sales from its cholesterol drug, Lopid,@#%^&*('allowed', 'ROOT', 'R')	
to power earnings growth.@#%^&*('growth', 'allowed', 'U')	
Lopid sales are expected to be about $300 million this year, up from $190 million in 1988.@#%^&*('expected', 'ROOT', 'R')	
In Morris Plains, N.J., a spokesman for the company said@#%^&*('said', 'ROOT', 'R')	('the', 'analysts', 'U')	
the analysts' projections are "in the ballpark."@#%^&*('are', 'said', 'U')	
Squibb's profit,@#%^&*('profit', 'result', 'U')	
estimated by analysts to be about 18% above the $123 million, or $1.25 a share,@#%^&*('estimated', 'profit', 'U')	
it earned in the third quarter of 1988,@#%^&*('earned', '%', 'U')	
was the result of especially strong sales of its Capoten drug@#%^&*('result', 'ROOT', 'R')	
for treating high blood pressure and other heart disease.@#%^&*('treating', 'drug', 'U')	
The company was officially merged with Bristol-Myers Co. earlier this month.@#%^&*('merged', 'ROOT', 'R')	
Bristol-Myers declined to comment.@#%^&*('declined', 'ROOT', 'R')	
Mr. Riccardo of Bear Stearns said@#%^&*('said', 'ROOT', 'R')	
that Schering-Plough Corp. 's expected profit rise of about 18% to 20%, and Bristol-Meyers's expected profit increase of about 13% are largely because "those companies are really managed well."@#%^&*('are', 'said', 'U')	
ScheringPlough earned $94.4 million, or 84 cents a share,@#%^&*('earned', 'ROOT', 'R')	
while Bristol-Myers earned $232.3 million, or 81 cents a share, in the like period a year earlier.@#%^&*
In Madison, N.J., a spokesman for Schering-Plough said@#%^&*('said', 'ROOT', 'R')	
the company has "no problems" with the average estimate by a analysts@#%^&*('has', 'said', 'U')	
that third-quarter earnings per share rose by about 19%, to $1.@#%^&*('rose', 'has', 'U')	
The company expects to achieve the 20% increase in full-year earnings per share,@#%^&*('expects', 'said', 'U')	('as', 'projected', 'U')	
as it projected in the spring,@#%^&*('projected', 'achieve', 'U')	('the', 'spokesman', 'U')	
the spokesman said.@#%^&*('said', 'ROOT', 'R')	
Meanwhile, analysts said@#%^&*('said', 'ROOT', 'R')	
Pfizer's recent string of lackluster quarterly performances continued,@#%^&*('continued', 'said', 'U')	
as earnings in the quarter were expected to decline by about 5%.@#%^&*('expected', 'continued', 'U')	
Sales of Pfizer's important drugs, Feldene@#%^&*('Sales', 'shrunk', 'U')	
for treating arthritis,@#%^&*('treating', 'Feldene', 'U')	
and Procardia, a heart medicine, have shrunk@#%^&*('Procardia', 'Sales', 'U')	('Procardia', 'Feldene', 'U')	('shrunk', 'ROOT', 'R')	
because of increased competition.@#%^&*('competition', 'shrunk', 'U')	
"The (strong) dollar hurt Pfizer a lot, too,"@#%^&*('hurt', 'said', 'U')	
Mr. Sweig said.@#%^&*('said', 'ROOT', 'R')	
In the third quarter last year, Pfizer earned $216.8 million, or $1.29 a share.@#%^&*('earned', 'ROOT', 'R')	
In New York, the company declined comment.@#%^&*('declined', 'ROOT', 'R')	
Analysts said@#%^&*('said', 'ROOT', 'R')	
they expected Upjohn's profit to be flat or rise by only about 2% to 4%@#%^&*('expected', 'said', 'U')	
as compared with $89.6 million, or 49 cents a share,@#%^&*('as', 'earned', 'U')	('with', 'earned', 'U')	('$', 'earned', 'U')	('cents', 'earned', 'U')	('it', 'earned', 'U')	
it earned a year ago.@#%^&*('earned', 'rise', 'U')	
Upjohn's biggest-selling drugs are Xanax, a tranquilizer, and Halcion, a sedative.@#%^&*('Xanax', 'ROOT', 'R')	
Sales of both drugs have been hurt by new state laws@#%^&*('hurt', 'ROOT', 'R')	
restricting the prescriptions of certain tranquilizing medicines@#%^&*('restricting', 'laws', 'U')	
and adverse publicity about the excessive use of the drugs.@#%^&*('publicity', 'restricting', 'U')	('publicity', 'prescriptions', 'U')	
Also, the company's hair-growing drug, Rogaine, is selling well@#%^&*('selling', 'said', 'U')	
-- at about $125 million for the year,@#%^&*('$', 'selling', 'U')	('the', 'company', 'U')	
but the company's profit from the drug has been reduced by Upjohn's expensive print and television campaigns for advertising,@#%^&*('reduced', 'selling', 'U')	('reduced', 'said', 'U')	
analysts said.@#%^&*('said', 'ROOT', 'R')	
In Kalamazoo, Mich., Upjohn declined comment.@#%^&*('declined', 'ROOT', 'R')	
